foxo4-dri senolytic 2024 regulates endothelial cell senescence via the P53 signaling pathway Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv As we age, the body accumulates Senescent Cells Mousai Wellness Center The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series JACC: Basic to Translational Science FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)
Pay in 4 interest-free payments of $5.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17




